Event Date/Time: Feb 05, 2012
End Date/Time: Feb 10, 2012
Feb 05, 2012
Early Registration Date:
Dec 05, 2011
In the last decade, cytokine therapies have been included as the standard of care for the treatment of infectious disease and cancer, and cytokine antagonists have been deployed for the management of chronic inflammation. Many researchers in this field are interested in basic principles through which cytokines mediate communication with and between cells of the immune system. Others are interested in the contributions of cytokines and cytokine signaling to the development of, or protection from, a broad range of diseases including allergy, infectious diseases, cancer, atherosclerosis and autoimmunity. With the recognition that many of these pathways impact broadly on multiple conditions, the goal of the Keystone Symposia meeting on The Biology of Cytokines is to promote interaction between scientists who study the molecular mechanisms of cytokine function, signal transduction and gene expression, and scientists who study how cytokines work in vivo. We anticipate that this meeting will foster discussion aimed at translating this knowledge into novel therapies for human disease. Opportunities for interdisciplinary interaction will be significantly enhanced by the concurrent meeting on Th17 Cells in Health and Disease, which will share a keynote address and two plenary sessions with this meeting.
This meeting is held jointly with the Keystone Symposia meeting "Th17 Cells in Health and Disease."
Registering for one meeting in a set of joint meetings enables participateion in sessions of the other, pending space availability.
Abstract & scholarship - October 5, 2011
Late-breaking abstract - November 7, 2011